Does left atrial appendage closure cause less bleeding than NOACs for Nonvalvular Atrial Fibrillation?
For people with nonvalvular atrial fibrillation (AF), both left atrial appendage closure (LAAC) and NOACs (direct oral anticoagulants) are used to prevent strokes. The key difference is that LAAC is a one-time procedure that mechanically seals off the left atrial appendage, while NOACs are daily pills that thin the blood. Because NOACs increase bleeding risk throughout the body, LAAC may be a better option for patients who are at high risk for bleeding. Recent studies show that LAAC leads to significantly fewer non-procedural bleeding events compared to NOACs, while still providing effective stroke prevention.
What the research says
A 2024 network meta-analysis found that low-dose NOACs were ranked best for preventing major bleeding, but left atrial appendage occlusion (LAAO) was ranked best for preventing hemorrhagic stroke and was comparable to NOACs for overall safety 1. However, a more recent synthesis of four randomized controlled trials (CHAMPION-AF, OPTION, PRAGUE-17, CLOSURE-AF) including 5,890 patients showed that LAAC achieved a 45-56% reduction in non-procedural bleeding compared to NOACs in moderate-risk patients 2. This bleeding reduction was consistent across trials, even in CLOSURE-AF which did not meet noninferiority for efficacy 2. A 2026 review also confirms that large trials and registries have found LAAC provides stroke prevention comparable to oral anticoagulation with fewer hemorrhagic complications 7. It is important to note that LAAC requires a short period of antithrombotic therapy after the procedure to prevent device-related thrombus, and the optimal regimen is still being studied 67. Overall, the evidence strongly supports that LAAC causes less bleeding than NOACs, especially in patients who cannot tolerate long-term anticoagulation.
What to ask your doctor
- Based on my personal bleeding risk (e.g., HAS-BLED score), would LAAC or a NOAC be safer for me?
- What is the expected reduction in bleeding risk with LAAC compared to taking a NOAC long-term?
- After LAAC, what antithrombotic medications will I need and for how long?
- How does my stroke risk (CHA2DS2-VASc score) influence the choice between LAAC and NOACs?
- Are there any specific risks of the LAAC procedure itself that I should consider?
This question is drawn from common patient questions about Cardiology and answered using cited medical research. We do not provide individualized advice.